Remove Life Science Remove Nurses Remove Pharmacy
article thumbnail

Haven: The strategy that didn’t fix healthcare

pharmaphorum

Dimon was peppered with questions about the end state vision for the joint-venture and its roadmap to get there, especially after Amazon purchased online pharmacy PillPack. The next healthcare (+ life sciences) will emerge in the zone where human and computational assemblages can do extraordinary things. About the author.

Marketing 126
article thumbnail

Top 10 Fastest Growing Healthcare Companies in 2024

XTalks

In an era where healthcare and life sciences are at the forefront of innovation and progress, identifying the fastest growing companies in this sector provides insights into where the industry is headed. TransparentRx (Rank 71) TransparentRx , founded in 2014, is leading the charge towards transparency in pharmacy benefits management.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Ways to Fast Track Your Career in Clinical Research

XTalks

The company looks for recent graduates of life science and nursing programs from a number of universities across North America, Europe and the Asia-Pacific (APAC) region. People come to clinical research from a multitude of different backgrounds, from nursing to pharmacy. Leverage Your Unique Experience.

article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

Patient access solutions, including hubs and specialty pharmacies, play a vital role in getting patients started on therapy. Dispensing pharmacies, while incentive-aligned on starting and keeping patients on therapy, may not have the tools, time, or incentives to secure the lowest out-of-pocket pricing for the patient.

article thumbnail

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

XTalks

The survey found that primary care providers accounted for 73 percent of first-time GLP-1 prescribers (60 percent), followed by physician assistants (seven percent) and nurse practitioners (six percent). The findings also highlighted challenges with access and cost, which affected patients’ ability to stay on their medication.

Drugs 105
article thumbnail

How the US’s pending PIE Act will improve patient access to medication

pharmaphorum

Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. . Jennifer L.

article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

Cohen says this new infrastructure has been unveiled at Fortrea’s Leeds location in the UK and expanded to a couple of US clinics to include new Current Good Manufacturing Practice (CGMP) pharmacies. They are unique and require specific expertise.” FIH studies involve a lot of risk.